NCT06717880 2025-02-12
A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)